The influence of organisational management on door-to-needle times for fibrinolytic treatment

Neurologia (Engl Ed). 2023 Jun;38(5):313-318. doi: 10.1016/j.nrleng.2020.10.010. Epub 2022 Jul 13.

Abstract

Introduction: Door-to-needle time (DNT) has been established as the main indicator in code stroke protocols. According to the 2018 guidelines of the American Heart Association/American Stroke Association, DNT should be less than 45minuts; therefore, effective and revised pre-admission and in-hospital protocols are required.

Method: We analysed organisational changes made between 2011 and 2019 and their influence on DNT and the clinical progression of patients treated with fibrinolysis. We collected data from our centre, stored and monitored under the Master Plan for Cerebrovascular Disease of the regional government of Catalonia. Among other measures, we analysed the differences between years and differences derived from the implementation of the Helsinki model.

Results: The study included 447 patients, and we observed significant differences in DNT between different years. Pre-hospital code stroke activation, recorded in 315 cases (70.5%), reduced DNT by a median of 14minutes. However, the linear regression model only showed an inversely proportional relationship between the adoption of the Helsinki code stroke model and DNT (beta coefficient, -0.42; P<.001). The removal of vascular neurologists after the adoption of the Helsinki model increased DNT and the 90-day mortality rate.

Conclusion: DNT is influenced by the organisational model. In our sample, the application of the Helsinki model, the role of the lead vascular neurologist, and notification of code stroke by pre-hospital emergency services are key factors for the reduction of DNT and the clinical improvement of the patient.

Keywords: Acute stroke; Cambios organizativos; Door-to-needle time; Ictus agudo; Intravenous thrombolysis; Organisational changes; Protocolos; Protocols; Tiempo puerta-aguja; Trombolisis intravenosa.

MeSH terms

  • Emergency Service, Hospital
  • Hospitals
  • Humans
  • Stroke* / drug therapy
  • Thrombolytic Therapy / methods
  • Time-to-Treatment*
  • United States